Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
The epigenetics of autoimmune diseases [[electronic resource] /] / edited by Moncef Zouali
| The epigenetics of autoimmune diseases [[electronic resource] /] / edited by Moncef Zouali |
| Pubbl/distr/stampa | Chichester ; ; Hoboken, NJ, : Wiley-Blackwell, 2009 |
| Descrizione fisica | 1 online resource (473 p.) |
| Disciplina |
571.9/73
571.973 616.978042 |
| Altri autori (Persone) | ZoualiMoncef <1952-> |
| Soggetto topico |
Autoimmunity - Molecular aspects
Autoimmune diseases - Etiology Post-translational modification Epigenesis |
| ISBN |
1-282-13817-0
9786612138171 0-470-74355-7 0-470-74356-5 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
The Epigenetics of Autoimmune Diseases; Contents; Preface; Contributors; PART I Transcription Factors: Partners of Immune Tolerance to Self; 1 Transcriptional regulation of T cell tolerance; 1.1 Introduction; 1.2 T cell anergy; 1.3 Ca2+/calcineurin/NFAT signalling in T cell anergy; 1.4 Transcriptional programme of T cell anergy; 1.5 Transcriptional repression in T cell anergy: epigenetic modification of the Il2 promoter; 1.6 Regulatory T cells; 1.7 Transcriptional control of Treg development and function; References; 2 Epigenetic regulation of Foxp3 expression in regulatory T cells
2.1 Introduction2.2 Naturally occurring CD25+ CD4+ Tregs; 2.3 The transcription factor FOXP3: determining Treg function and identity; 2.4 Molecular regulation of FOXP3; 2.5 Tregs as a stable lineage: indications of epigenetic imprinting; 2.6 Induced Tregs: stable suppressors or transient immuno-modulators?; 2.7 Conclusions; References; 3 The role of NF-kB in central tolerance; 3.1 Introduction; 3.2 Canonical and alternative NF-kB pathways; 3.3 Thymic stroma and central tolerance; 3.4 NF-kB and regulatory T cell development; 3.5 NF-kB and thymocyte positive and negative selection 3.6 Conclusions and perspectives3.7 Acknowledgement; References; 4 The role of Act1 in the control of autoimmunity; 4.1 Introduction; 4.2 Autoimmunity and autoimmune mouse models; 4.3 Molecular mechanisms of autoimmunity; 4.4 Act1: a modulator of autoimmunity; 4.5 Conclusions; References; 5 Regulation of T cell anergy and escape from regulatory T cell suppression by Cbl-b; 5.1 Introduction; 5.2 Mechanisms of T cell tolerance induction; 5.3 Molecular establishment of T cell anergy; 5.4 Ubiquitin E3 ligases in T cell tolerance; 5.5 Molecular function and regulation of Cbl-b 5.6 Physiological relevance of Cbl-b5.7 The role of Cbl-b in T cell tolerance; 5.8 Deregulation of Cbl-b in disease; 5.9 Therapeutic potential of Cbl-b in tumour immunity; 5.10 Implications for autoimmune disease; References; 6 Indoleamine 2,3-dioxygenase: transcriptional regulation and autoimmunity; 6.1 Introduction; 6.2 L-Trp degradation along the kynurenine pathway and immune functions of IDO; 6.3 IDO immunobiology and therapeutic intervention; 6.4 Transcriptional regulation of the IDO-encoding gene; 6.5 Impaired IDO activity and loss of tolerance in autoimmune diseases 6.6 IDO-based therapies for autoimmune disease6.7 Acknowledgement; References; PART II Stress Responses that Break Immune Silence; 7 Chromatin modifications, oxidative stress and nucleosome autoantibodies; 7.1 Introduction; 7.2 Nucleosome and SLE; 7.3 Epigenetics and SLE; 7.4 Oxidative stress in SLE: definition and mechanisms; 7.5 Oxidative stress, epigenetic alterations and nucleosome immunogenicity; 7.6 Conclusion; 7.7 Acknowledgements; References; 8 Stress, epigenetics and thyroid autoimmunity; 8.1 Introduction; 8.2 The Th1/Th2 balance in immune-response regulation 8.3 Stress hormones and the Th1/Th2 balance |
| Record Nr. | UNINA-9910146133703321 |
| Chichester ; ; Hoboken, NJ, : Wiley-Blackwell, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The epigenetics of autoimmune diseases [[electronic resource] /] / edited by Moncef Zouali
| The epigenetics of autoimmune diseases [[electronic resource] /] / edited by Moncef Zouali |
| Pubbl/distr/stampa | Chichester ; ; Hoboken, NJ, : Wiley-Blackwell, 2009 |
| Descrizione fisica | 1 online resource (473 p.) |
| Disciplina |
571.9/73
571.973 616.978042 |
| Altri autori (Persone) | ZoualiMoncef <1952-> |
| Soggetto topico |
Autoimmunity - Molecular aspects
Autoimmune diseases - Etiology Post-translational modification Epigenesis |
| ISBN |
1-282-13817-0
9786612138171 0-470-74355-7 0-470-74356-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
The Epigenetics of Autoimmune Diseases; Contents; Preface; Contributors; PART I Transcription Factors: Partners of Immune Tolerance to Self; 1 Transcriptional regulation of T cell tolerance; 1.1 Introduction; 1.2 T cell anergy; 1.3 Ca2+/calcineurin/NFAT signalling in T cell anergy; 1.4 Transcriptional programme of T cell anergy; 1.5 Transcriptional repression in T cell anergy: epigenetic modification of the Il2 promoter; 1.6 Regulatory T cells; 1.7 Transcriptional control of Treg development and function; References; 2 Epigenetic regulation of Foxp3 expression in regulatory T cells
2.1 Introduction2.2 Naturally occurring CD25+ CD4+ Tregs; 2.3 The transcription factor FOXP3: determining Treg function and identity; 2.4 Molecular regulation of FOXP3; 2.5 Tregs as a stable lineage: indications of epigenetic imprinting; 2.6 Induced Tregs: stable suppressors or transient immuno-modulators?; 2.7 Conclusions; References; 3 The role of NF-kB in central tolerance; 3.1 Introduction; 3.2 Canonical and alternative NF-kB pathways; 3.3 Thymic stroma and central tolerance; 3.4 NF-kB and regulatory T cell development; 3.5 NF-kB and thymocyte positive and negative selection 3.6 Conclusions and perspectives3.7 Acknowledgement; References; 4 The role of Act1 in the control of autoimmunity; 4.1 Introduction; 4.2 Autoimmunity and autoimmune mouse models; 4.3 Molecular mechanisms of autoimmunity; 4.4 Act1: a modulator of autoimmunity; 4.5 Conclusions; References; 5 Regulation of T cell anergy and escape from regulatory T cell suppression by Cbl-b; 5.1 Introduction; 5.2 Mechanisms of T cell tolerance induction; 5.3 Molecular establishment of T cell anergy; 5.4 Ubiquitin E3 ligases in T cell tolerance; 5.5 Molecular function and regulation of Cbl-b 5.6 Physiological relevance of Cbl-b5.7 The role of Cbl-b in T cell tolerance; 5.8 Deregulation of Cbl-b in disease; 5.9 Therapeutic potential of Cbl-b in tumour immunity; 5.10 Implications for autoimmune disease; References; 6 Indoleamine 2,3-dioxygenase: transcriptional regulation and autoimmunity; 6.1 Introduction; 6.2 L-Trp degradation along the kynurenine pathway and immune functions of IDO; 6.3 IDO immunobiology and therapeutic intervention; 6.4 Transcriptional regulation of the IDO-encoding gene; 6.5 Impaired IDO activity and loss of tolerance in autoimmune diseases 6.6 IDO-based therapies for autoimmune disease6.7 Acknowledgement; References; PART II Stress Responses that Break Immune Silence; 7 Chromatin modifications, oxidative stress and nucleosome autoantibodies; 7.1 Introduction; 7.2 Nucleosome and SLE; 7.3 Epigenetics and SLE; 7.4 Oxidative stress in SLE: definition and mechanisms; 7.5 Oxidative stress, epigenetic alterations and nucleosome immunogenicity; 7.6 Conclusion; 7.7 Acknowledgements; References; 8 Stress, epigenetics and thyroid autoimmunity; 8.1 Introduction; 8.2 The Th1/Th2 balance in immune-response regulation 8.3 Stress hormones and the Th1/Th2 balance |
| Record Nr. | UNINA-9910830763503321 |
| Chichester ; ; Hoboken, NJ, : Wiley-Blackwell, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The epigenetics of autoimmunity / / edited by Rongxin Zhang, Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China
| The epigenetics of autoimmunity / / edited by Rongxin Zhang, Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China |
| Pubbl/distr/stampa | London : , : Academic Press an imprint of Elsevier, , 2018 |
| Descrizione fisica | 1 online resource (xix, 411 pages) : illustrations |
| Disciplina | 571.973 |
| Collana | Translational epigenetics series |
| Soggetto topico |
Autoimmunity - Molecular aspects
Autoimmune diseases - Etiology Epigenesis Autoimmunity Epigenesis, Genetic - immunology |
| ISBN |
0-12-809928-3
0-12-809912-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. The epigenetics of autoimmunity: an overview -- 2. Immune cell development and epigenetics -- 3. DNA methylation and histone modifications in autoimmunity -- 4. MicroRNA and T helper cell-mediated immune responses -- 5. Long noncoding RNAs in the immune response -- 6. Epigenetics of systemic lupus erythematosus -- 7. Rheumatoid arthritis and epigenetics -- 8. Epigenetic modifications in multiple sclerosis pathophysiology: potential diagnostic and therapeutic applications -- 9. Type 1 diabetes and epigenetics -- 10. Systemic sclerosis and epigenetics -- 11. Primary Sjogren's syndrome and epigenetics -- 12. Autoimmune thyroid diseases and epigenetics -- 13. The epigenetics of primary biliary cholangitis -- 14. Immune-mediated pulmonary disease and epigenetics -- 15. The epigenetics of autoimmunity and epigenetic drug discovery -- 16. Treatment of autoimmune diseases and prevention of transplant rejection and graft-versus-host disease by regulatory T cells: the state of the art and perspectives -- 17. Noncoding RNA-targeted therapeutics in autoimmune diseases: from bench to bedside -- 18. Future challenges and prospects for the epigenetics of autoimmunity. |
| Record Nr. | UNINA-9910583038803321 |
| London : , : Academic Press an imprint of Elsevier, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||